https://www.zacks.com/stock/news/2202961/is-ishares-esg-aware-msci-usa-etf-esgu-a-strong-etf-right-now?cid=CS-ZC-FT-smart_beta_etf-2202961
Dec 28, 2023 - Smart Beta ETF report for ESGU
zc:-3836365574625311425
0
https://www.zacks.com/stock/news/2202750/why-you-should-invest-in-encompass-health-ehc-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202750
Dec 27, 2023 - Encompass Health (EHC) is well-poised for growth on the back of growing revenues, an aging U.S. population, joint ventures and solid cash reserves.
zc:-2616827096524770250
0
https://www.zacks.com/stock/news/2202740/rio-or-mp-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2202740
Dec 27, 2023 - RIO vs. MP: Which Stock Is the Better Value Option?
zc:2274885098033578234
0
https://www.zacks.com/stock/news/2202743/bbsi-vs-payx-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2202743
Dec 27, 2023 - BBSI vs. PAYX: Which Stock Is the Better Value Option?
zc:-5753297452409681628
0
https://www.zacks.com/stock/news/2202745/arco-or-cmg-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2202745
Dec 27, 2023 - ARCO vs. CMG: Which Stock Is the Better Value Option?
zc:-8720750810264722152
0
https://www.zacks.com/stock/news/2202748/grfs-or-zts-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2202748
Dec 27, 2023 - GRFS vs. ZTS: Which Stock Is the Better Value Option?
zc:9162618238248903796
0
https://www.zacks.com/stock/news/2202712/here-s-why-you-should-retain-wynn-resorts-wynn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202712
Dec 27, 2023 - Wynn Resorts (WYNN) focuses on concession-related capital endeavors to drive growth. However, a volatile macroeconomic environment is a concern.
zc:6117802435521512201
0
https://www.zacks.com/stock/news/2202701/here-s-why-you-should-avoid-investing-in-barnes-b-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202701
Dec 27, 2023 - Barnes (B) experiences weakness in its operations due to weakness in the Industrial segment. Rising costs are added concerns for the company.
zc:-8498956154018818611
0
https://www.zacks.com/stock/news/2202694/here-s-why-you-should-retain-cvs-health-cvs-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202694
Dec 27, 2023 - Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.
zc:5697746230444580253
0
https://www.zacks.com/stock/news/2202692/reasons-why-you-should-hold-on-to-stericycle-srcl-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202692
Dec 27, 2023 - Stericycle (SRCL) is gaining from its transformation initiative launched in 2017 and its robust acquisition strategy.
zc:1431677921576427061
0